Chapter 3 then goes
on to discuss in some more detail the challenges of the
economic argument that revolve in particular around
the “value for money” assessment. The main challenges
include the attribution of the changes in health outcomes
to the intervention in question and the valuation of the
potentially multifaceted benefits of the intervention.